参考文献/References:
[1] Shimizu K, Kushamae M, Mizutani T, et al. Intracranial aneurysm as a macrophage-mediated inflammatory disease[J]. Neurol Med Chir(Tokyo), 2019, 59(4): 126-132.
[2] Li TF, Shui SF, Han XW, et al. One-Stage endovascular embolization for multiple intracranial aneurysms[J]. Turk Neurosurg, 2018, 28(1): 43-47.
[3] 鲁刚,蒋业清,葛亮,等.血管内栓塞治疗颅内动脉瘤的中长期临床随访研究[J].中华神经外科杂志,2017,33(8):794-798.
[4] Ma F, Wang Z, Abdularab A, et al. Matrix metalloproteinase 9 and prostate cancer risk: a meta-analysis of 1059 participants[J]. Minerva Urol Nefrol, 2017, 69(4): 324-329.
[5] Streitberger KJ, Leithner C, Wattenberg M, et al. Neuron-Specific enolase predicts poor outcome after cardiac arrest and targeted temperature management: A multicenter study on 1,053 patients[J]. Crit Care Med, 2017, 45(7): 1145-1151.
[6] Kampan NC, Xiang SD, Mcnally OM, et al. Immunotherapeutic interleukin-6 or interleukin-6 receptor blockade in cancer: Challenges and opportunities[J]. Curr Med Chem, 2018, 25(36): 4785-4806.
[7] Sawyer DM, Lauren AP, Crissey LP, et al. Lymphocytes influence intracranial aneurysm formation and rupture: role of extracellular matrix remodeling and phenotypic modulation of vascular smooth muscle cells[J]. J Neuroinflammation, 2016, 13(1): 185-193.
[8] Abboud T, Mende KC, Jung R, et al. Prognostic value of early S100 Calcium binding protein B and Neuron-Specific enolase in patients with Poor-Grade aneurysmal subarachnoid hemorrhage: a pilot study[J]. World Neurosurg, 2017, 108(1): 669-675.
[9] Woertgen C, Ullrich OW, Rothoerl RD, et al. Comparison of the claassen and fisher CT classification scale to predict ischemia after aneurysmatic SAH?[J]. Zentralbl Neurochir, 2003, 64(3): 104-108.
[10] Mericle RA, Reig AS, Burry MV, et al. Endovascular surgery for proximal posterior inferior cerebellar artery aneurysms: An analysis of glasgow outcome score by Hunt-Hess grades[J]. Neurosurgery, 2006, 58(4): 619-625; discussion 619-25.
[11] 徐兴国,杨振兴,陈一笑,等.血管内治疗破裂颅内动脉瘤患者的预后影响因素分析[J].中华神经外科杂志,2017,33(1):49-53.
[12] Shikata F, Shimada K, Sato H, et al. Potential influences of gut microbiota on the formation of intracranial aneurysm[J]. Hypertension, 2019, 73(2): 491-496.
[13] Kim T, Lee H, Ahn S, et al. Incidence and risk factors of intracranial aneurysm: A national cohort study in Korea[J]. International Journal of Stroke, 2016, 11(8, SI): 917-927.
[14] 康慧斌,刘爱华,李佑祥,等.影响颅内动脉瘤破裂的临床危险因素分析[J].中华神经外科杂志,2018,34(10):1012-1016.
[15] Dilvesi D, Cigic T, Papic V, et al. The fisher grade in predicting a degree of cerebral vasospasm in patients after intracranial aneurysm rupture[J]. Vojnosanit Pregl, 2016, 73(4): 349-352.
[16] 吴明,张欣玉,石锋,等.动脉瘤性蛛网膜下腔出血的CT分型与Hunt-Hess分级及预后的相关性分析[J].临床放射学杂志,2018,37(7):1078-1081.
[17] Kalani A, Pushpakumar SB, Vacek JC, et al. Inhibition of MMP-9 attenuates hypertensive cerebrovascular dysfunction in Dahl salt-sensitive rats[J]. Mol Cell Biochem, 2016, 413(1/2): 25-35.
[18] Zou L, Hou Y, Yu BX, et al. The effect of intravascular interventional embolization and craniotomy on MMP-2, MMP-9 and caspase3 in serum of intracranial aneurysm patients[J]. Exp Ther Med, 2018, 16(6): 4511-4518.
[19] El SM, El-Raggal NM, El-Farrash RA, et al. Cerebral blood flow and serum neuron-specific enolase in early-onset neonatal sepsis[J]. Pediatr Res, 2018, 84(2): 261-266.
[20] 吴康丽,陈秀侠,谢晨阳,等.左上肢上臂缺血预处理开颅动脉瘤夹闭术患者血清NSE、S100β蛋白、脑红蛋白水平观察[J].山东医药,2019,59(9):11-14.
[21] Hosaka K, Rojas K, Fazal HZ, et al. Monocyte chemotactic protein-1-Interleukin-6-Osteopontin pathway of Intra-Aneurysmal tissue healing[J]. Stroke, 2017, 48(4): 1052-1060.
[22] Duri K, Neuman E, Vybíhal V, et al. Early dynamics of interleukin-6 in cerebrospinal fluid after aneurysmal subarachnoid hemorrhage[J]. J Neurol Surg A Cent Eur Neurosurg, 2018, 79(2): 145-151.
[23] 卢俏丽,李晨,贾志荣.炎症介质hs-CRP、IL-6和MMP-9水平与脑微出血的相关性研究[J].重庆医学,2017,46(26):3629-3631.
[24] 高继英,石代乐,高晓玲,等.高血压脑出血术后应用高压氧治疗对患者血清MMP-9、ICAM-1、NSE、hs-CRP水平的影响[J].山东医药,2019,59(14):80-82.